Study of the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Characteristics of PA1010 in HBV Patients
Status:
Recruiting
Trial end date:
2022-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety, tolerability, pharmacokinetic
and pharmacodynamic characteristics of multiple ascending dose (MAD) of PA1010 tablets in
Chinese adults with Chronic Hepatitis B.